๐Ÿ•ต๏ธ Enanta Pharmaceuticals Inc ($ENTA)

SEC insider & ownership activity, last 12 months ยท CIK 1177648 ยท every row links its SEC filing

Over the last 12 months insiders sold $183K with no open-market buying against it. Jay R. Luly sold $67K in discretionary trades (Dec). No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net -$183K Jan 2026: net +$0 Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) ยท 7 sellers, $183K (9 lots)

InsiderBuysBoughtSellsSoldLast
Jay R. Luly0โ€“ 1$67KDec 5, 2025
Or Yat Sun0โ€“ 1$34KDec 5, 2025
Kieffer Tara Lynn0โ€“ 1$30KDec 5, 2025
Luu Brendan0โ€“ 1$20KDec 5, 2025
Harry R. Trout III0โ€“ 2$13KDec 5, 2025
Scott T. Rottinghaus0โ€“ 1$11KDec 5, 2025
Kathleen S. Capps0โ€“ 2$7KDec 5, 2025

5%+ holders

HolderStakeClassScheduleEvent
Janus Henderson Group PLC 12.1% 13GNov 7, 2025 filing โ†—
Janus Henderson Biotech Innovation Master Fund Ltd 10.6% 13GNov 7, 2025 filing โ†—
Joshua J. Dapice 9.8% 13GFeb 5, 2026 filing โ†—
Dreyfuss, Philip D. 9.8% 13GFeb 5, 2026 filing โ†—
Hannah E. Dunn 9.8% 13GFeb 5, 2026 filing โ†—
Gehani, Varun N. 9.8% 13GFeb 5, 2026 filing โ†—
Giauque, Nicolas 9.8% 13GFeb 5, 2026 filing โ†—
Husen, Avner A. 9.8% 13GFeb 5, 2026 filing โ†—
KIM, David T. 9.8% 13GFeb 5, 2026 filing โ†—
LINN, Michael G. 9.8% 13GFeb 5, 2026 filing โ†—
LUO Patrick (CHENG) 9.8% 13GFeb 5, 2026 filing โ†—
Roberts, JR., Thomas G. 9.8% 13GFeb 5, 2026 filing โ†—
Edric C. Saito 9.8% 13GFeb 5, 2026 filing โ†—
Daniel S. Short 9.8% 13GFeb 5, 2026 filing โ†—
Spokes, Andrew J. M. 9.8% 13GFeb 5, 2026 filing โ†—
Warren, JOHN R. 9.8% 13GFeb 5, 2026 filing โ†—
Wehrly, MARK C. 9.8% 13GFeb 5, 2026 filing โ†—
Farallon Partners, L.L.C. 9.1% 13GFeb 5, 2026 filing โ†—
Blackrock, Inc. 7.8% 13GApr 17, 2025 filing โ†—
JAY R. LULY, PH.D. 7.7% 13DFeb 12, 2025 filing โ†—
DEEP Track Capital, LP 6.8% 13GFeb 13, 2026 filing โ†—
DEEP Track Biotechnology Master Fund, Ltd. 6.8% 13GFeb 13, 2026 filing โ†—
David Kroin 6.8% 13GFeb 13, 2026 filing โ†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Jay R. Luly$68KDec 5, 2025 filing โ†—

Material events (8-K)

ItemEvent date
Material agreement (1.01)Jul 2, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 2, 2026 filing โ†—
Other events (8.01)Jun 23, 2026 filing โ†—
Reg FD disclosure (7.01)Jun 18, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 18, 2026 filing โ†—
Earnings (2.02)May 11, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 11, 2026 filing โ†—
Other events (8.01)Mar 20, 2026 filing โ†—
Officer/director changes (5.02)Mar 11, 2026 filing โ†—
Shareholder vote (5.07)Mar 11, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 11, 2026 filing โ†—
Earnings (2.02)Feb 9, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Feb 9, 2026 filing โ†—
Earnings (2.02)Nov 17, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 17, 2025 filing โ†—
Other events (8.01)Sep 30, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Sep 30, 2025 filing โ†—
Reg FD disclosure (7.01)Sep 29, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Sep 29, 2025 filing โ†—
Reg FD disclosure (7.01)Sep 29, 2025 filing โ†—
Other events (8.01)Sep 29, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Sep 29, 2025 filing โ†—
Officer/director changes (5.02)Aug 26, 2025 filing โ†—
Reg FD disclosure (7.01)Aug 20, 2025 filing โ†—
Other events (8.01)Aug 20, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Aug 20, 2025 filing โ†—
Earnings (2.02)Aug 11, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Aug 11, 2025 filing โ†—